AltrixBio Inc.
PrivateLast Round
Series A
Sep 16, 2025
Total Funding Raised
$6.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
AltrixBio Inc. operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series A round in September 2025.
AltrixBio Inc. is a biotechnology company that develops non-systemic oral therapies designed to replicate the metabolic benefits of bariatric surgery for the treatment of type 2 diabetes and obesity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AltrixBio Inc. Comparables
Compare AltrixBio Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Syntis Bio, Inc. | 93% | |
| Glyscend Therapeutics | 91% | |
| Kallyope | 79% |
For institutional investors. Book with your work email.
AltrixBio Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 16, 2025 | ||||
| Seed | Nov 6, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AltrixBio Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arizona Tech Investors | Seed |
| Taihill Venture | Seed |
| MIT Alumni Angels | Seed |
| XFactor Ventures | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 79% MoM, reaching 3.8K.
- Jul 24, 2026
Monthly visitors increased 33% MoM.
For institutional investors. Book with your work email.
AltrixBio Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AltrixBio Inc.'s valuation, stock price, and market status.
Is AltrixBio Inc. a public or private company?
AltrixBio Inc. is a private company.
What is the current stock price of AltrixBio Inc.?
AltrixBio Inc. is a private company, so its shares have no public market price. Caplight tracks AltrixBio Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AltrixBio Inc. worth (valuation)?
Valuation information for AltrixBio Inc. is not publicly available.
Can I buy AltrixBio Inc. stock?
AltrixBio Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AltrixBio Inc.'s last funding round?
AltrixBio Inc.'s most recent funding round was Series A on September 16, 2025.
Who are the main investors in AltrixBio Inc.?
Key investors in AltrixBio Inc. include Arizona Tech Investors, Taihill Venture, MIT Alumni Angels, XFactor Ventures.
Will AltrixBio Inc. IPO soon?
No public IPO plans have been announced for AltrixBio Inc..
How can I track AltrixBio Inc. secondary market activity?
Caplight tracks bids, offers, and trades in AltrixBio Inc.'s shares on secondary markets.